These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17266508)

  • 1. Trans-platinum complexes in cancer therapy.
    Coluccia M; Natile G
    Anticancer Agents Med Chem; 2007 Jan; 7(1):111-23. PubMed ID: 17266508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
    Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
    Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of trans geometry in bifunctional mononuclear platinum complexes by a non-bulky methylamine ligand.
    Frybortova M; Novakova O; Stepankova J; Novohradsky V; Gibson D; Kasparkova J; Brabec V
    J Inorg Biochem; 2013 Sep; 126():46-54. PubMed ID: 23770803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties.
    Intini FP; Boccarelli A; Francia VC; Pacifico C; Sivo MF; Natile G; Giordano D; De Rinaldis P; Coluccia M
    J Biol Inorg Chem; 2004 Sep; 9(6):768-80. PubMed ID: 15241660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fresh platinum complexes with promising antitumor activity.
    Wang X
    Anticancer Agents Med Chem; 2010 Jun; 10(5):396-411. PubMed ID: 20545618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
    Kasparkova J; Novakova O; Farrell N; Brabec V
    Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
    Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
    J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reaction of Histone H1 with trans-Platinum Complexes and the Effect on DNA Platination.
    Cheng L; Li C; Yuan S; Shi H; Zhao L; Zhang L; Arnesano F; Natile G; Liu Y
    Inorg Chem; 2019 May; 58(9):6485-6494. PubMed ID: 31021622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoactivatable platinum complexes.
    Bednarski PJ; Mackay FS; Sadler PJ
    Anticancer Agents Med Chem; 2007 Jan; 7(1):75-93. PubMed ID: 17266506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells.
    O'Neill CF; Hunakova L; Kelland LR
    Chem Biol Interact; 1999 Nov; 123(1):11-29. PubMed ID: 10597899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization, and biological activity of platinum II, III, and IV pivaloamidine complexes.
    Sinisi M; Gandin V; Saltarella T; Intini FP; Pacifico C; Marzano C; Natile G
    J Biol Inorg Chem; 2014 Oct; 19(7):1081-97. PubMed ID: 24850131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-platinum complexes as anticancer drugs: recent developments and future prospects.
    Radulovic S; Tesic Z; Manic S
    Curr Med Chem; 2002 Sep; 9(17):1611-8. PubMed ID: 12171556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and activity of three new trinuclear platinums with cis-geometry for terminal metal centres.
    Hamad SA; Beale P; Yu JQ; Huq F
    J Biomed Sci; 2014 May; 21(1):41. PubMed ID: 24884683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of the development of trans-platinum antitumor drugs.
    Pérez JM; Fuertes MA; Alonso C; Navarro-Ranninger C
    Crit Rev Oncol Hematol; 2000 Aug; 35(2):109-20. PubMed ID: 10936468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2].
    Brabec V; Vrána O; Nováková O; Kleinwächter V; Intini FP; Coluccia M; Natile G
    Nucleic Acids Res; 1996 Jan; 24(2):336-41. PubMed ID: 8628659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.
    Kelland LR; Sharp SY; O'Neill CF; Raynaud FI; Beale PJ; Judson IR
    J Inorg Biochem; 1999 Oct; 77(1-2):111-5. PubMed ID: 10626362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
    Kelland LR; Barnard CF; Mellish KJ; Jones M; Goddard PM; Valenti M; Bryant A; Murrer BA; Harrap KR
    Cancer Res; 1994 Nov; 54(21):5618-22. PubMed ID: 7923207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.
    Novakova O; Kasparkova J; Malina J; Natile G; Brabec V
    Nucleic Acids Res; 2003 Nov; 31(22):6450-60. PubMed ID: 14602903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platinum(II) complexes containing iminoethers: a trans platinum antitumour agent.
    Coluccia M; Boccarelli A; Mariggiò MA; Cardellicchio N; Caputo P; Intini FP; Natile G
    Chem Biol Interact; 1995 Dec; 98(3):251-66. PubMed ID: 8548863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum-based drugs: past, present and future.
    Dilruba S; Kalayda GV
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1103-24. PubMed ID: 26886018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.